energy in essence
We know that partnering and working in collaboration with others are important to accelerate the development of innovative new medicines.
Khondrion coordinates and participates in several European research and educational initiatives in collaboration with academic and industrial partners, and has received financial support from European and local government grants to progress research. Most recently the company was awarded a multi-million Euro grant from the European Commission’s Horizon 2020 research and innovation programme to support development of KH176, Khondrion’s lead pipeline asset.
At Khondrion we are pursuing the newest science within our own labs and through collaborations across an extensive clinical and academic network, exploring new avenues of science and sharing knowledge of mitochondrial disease. If you are interested in being part of this, if you’re involved in work that may be relevant to Khondrion or if you would simply like to learn more about our research, then get in touch.